The aim of this study was to explore the money management problems in patients with multiple sclerosis, and to investigate the factors that contribute to these problems. This cross-sectional study included 30 adults with multiple sclerosis and 23 healthy controls. All subjects were assessed using a battery of neurophysiological tests, a money management survey, and a functional test for money management skills. The outcomes of patients were compared with those of healthy controls.
This study aimed to examine the current 10-year booster vaccination against tetanus and diphtheria. They evaluated the magnitude and duration of immunity to TDap vaccine to figure whether antibody responses decreased more rapidly in an older population. In previous studies, protective antibody titer was reported as ≥0.15 IU/mL for tetanus. Researchers believed that the threshold values of previous studies likely underestimated the levels of protection. In this cross-sectional survey, Hammarlund and colleagues performed analysis of serum antibody titers in 546 adults. They reported that approximately 97% of the population was seropositive to tetanus and diphtheria. Titers of antibody to tetanus declined with an estimated half-life of 14 years (95% confidence interval, 11-17 years), while titers of antibody to diphtheria were more lasting and declined with an estimated half-life of 27 years (18-51 years).
Mathematical analysis of the study predicted that 95% of the population would remain protected against tetanus and diphtheria for ≥30 years without necessitating booster vaccination. Based on these results, changing from a 10-year to The purpose of this study was to compare the efficacy of hyaluronic acid (hylan G-F 20) with triamcinolone acetonide as a single intra-articular injection for knee osteoarthritis. This study was a prospective, randomized, double-blind clinical trial. Participants with symptomatic knee osteoarthritis were recruited. They were randomized to receive a single-shot, intra-articular injection of either 6 mL of hylan G-F 20 or 6 mL of a solution comprising 1 mL of 40-mg triamcinolone acetonide and 5 mL of 1% lidocaine with epinephrine. The primary outcomes were knee pain severity, knee function, and range of motion at 6 months. Ninety-nine patients were assessed before injection and underwent a 6-month follow-up. The patients and evaluators were blinded.
Triamcinolone acetonide provided similar improvement in knee pain, function, and range of motion compared with hylan G-F 20 at the 6-month follow-up, with better pain control in the first week and better knee functional improvement in the second week.
